Coya Therapeutics, Inc. (COYY) IPO: A Clinical-Stage Biotech’s Bold Step onto Wall Street
A New Immunotherapy Challenger on Nasdaq
In 2025, Coya Therapeutics, Inc. (Nasdaq: COYY) — a Houston-based clinical-stage biotechnology company — completed its initial public offering,...
Rebellyous Foods, Inc. (RBLY) IPO: Plant-Based Protein Pioneer Makes a Public Debut
A Plant-Based Challenger Steps onto Wall Street
In mid-2025, Rebellyous Foods, Inc., a Seattle-based producer of plant-based meat alternatives, completed its initial public offering on...
Anew Health Eyes U.S. Market with $18.75M IPO on Nasdaq
The Hong Kong–based pain therapy provider seeks growth and credibility via American public listing
Anew Health, a Hong Kong–headquartered healthcare services company founded in 2007, is...
A Paradise Acquisition Files for $200 Million IPO: A New SPAC from Hong Kong Eyes the Leisure Market
With a clear focus on the leisure and entertainment sectors, this new SPAC aims to capitalize on post-pandemic consumer demand
In May 2025, a new...
Yunhong Green CTI Ltd. (YHGJ) IPO: Sustainable Packaging Pioneer Makes Its Nasdaq Debut
A New Sustainable Industry Entrant on Wall Street
In July 2025, Yunhong Green CTI Ltd., a China-based company specializing in environmentally friendly packaging solutions, completed...
